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Two forms of the classical progesterone receptors (PR), XPR-1 and XPR-2, have been cloned in Xenopus laevis. Their relative roles in
mediating progesterone action in the ovaries are not clear. Using antibodies generated against the cloned XPR-2, we demonstrated here that the
somatic follicle cells expressed an 80-kDa PR protein, termed XPR-1. Treatment of follicle cells with progesterone resulted in disappearance of
this protein, consistent with proteosome-mediated XPR-1 protein degradation. A smaller (¨70 kDa) PR protein, termed XPR-2, was expressed
in the oocytes, but not in follicle cells. XPR-2 underwent progesterone-induced phosphorylation but not protein degradation. Treating isolated
ovarian fragments with progesterone caused oocyte maturation and the release of the mature oocytes from the ovarian tissues (‘‘ovulation’’).
Inhibition of transcription, with actinomycin D, did not interfere with progesterone-induced oocyte maturation but blocked ‘‘ovulation’’ so that
mature oocytes were trapped in the follicles. These results suggest that the dual functions of progesterone, transcription-dependent follicle
rupture and transcription-independent oocyte maturation, are mediated by the two forms of PR proteins differentially expressed in the follicle
cells and the oocytes, respectively.
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Fully grown Xenopus oocytes are physiologically ar-
rested at late prophase of meiosis I. In sexually mature
females, the pituitary-derived gonadotropins trigger ovula-
tory responses which include resumption of meiotic matura-
tion of the oocytes (oocyte maturation) and the subsequent
release of the mature eggs from the follicles (ovulation).
Oocyte maturation is thought to be mediated by progester-
one, produced by the ovarian follicle cells in response to
gonadotropins (Masui and Clarke, 1979). However, the
follicles also produce high concentrations of androgens
(Fortune, 1983; Yang et al., 2003) and androgens are as0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: jliu@ohri.ca (X.J. Liu).potent as progesterone in inducing frog oocyte maturation in
vitro (Baulieu et al., 1978; Lutz et al., 2001). Progesterone
action in frog oocytes exhibits an unusual characteristic in
that it does not involve transcriptional regulation; therefore,
this ‘‘non-genomic’’ action of progesterone is distinct from
the ‘‘classical’’ action of progesterone which, through its
nuclear receptor (progesterone receptor or PR), activates
transcription of genes containing progesterone-response
elements. The identity of this ‘‘non-genomic’’ progesterone
receptor in frog oocytes had remained unknown for many
years.
We and others have identified two forms of PR from
Xenopus laevis, XPR-1 (Tian et al., 2000) (GenBank
accession no. AF279335) and XPR-2, previously called
xPR (Bayaa et al., 2000) (GenBank accession no.
AY007198). An independent clone of XPR-2 has been
deposited in the database (GenBank accession no.
AF319596). The two XPR-2 clones differ only in that one83 (2005) 180 – 190
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2 clone contains in-frame translation termination codons at
the 5V end; therefore, the sequence shown in Fig. 1 may
represent partial cDNA for XPR-2. XPR-1 and XPR-2 are
almost identical in the C-terminal hormone binding domain
and the central DNA-binding domain (Fig. 1). In contrast,
the N-terminal amino acid sequences are more divergent.
Over-expression of XPR-1 (Tian et al., 2000) or XPR-2
(Bayaa et al., 2000) enhances progesterone responses in frog
oocytes. These studies suggest that the classical progester-
one receptor may be responsible for the ‘‘non-genomic’’
action of progesterone in frog oocytes. However, the relative
contribution of the two forms of PR in mediating
progesterone response in frog oocytes or the mechanism
by which PR regulates ‘‘non-genomic’’ signaling in frog
oocytes remains unknown.
To further investigate the functional roles of PR in oocyte
maturation and ovulation in X. laevis, we sought to determine
the presence of PR in the somatic follicle cells vs. the oocytes
and the possible biochemical changes during oocyte matura-
tion and ovulation. These experiments revealed the presence
of a PR protein in the follicle cells (but not the oocytes) that
was indistinguishable from the cloned XPR-1; this PR wasFig. 1. Alignment of XPR-1 and XPR-2 coding sequences. BLAST alignment of
(Tian and Ruderman, GenBank accession no. AF319596). The most 5V ATG is d
DNA binding domain (double underlined) and hormone (progesterone) binding dom
Numbers denote amino acid positions in the conceptual translation.therefore termed XPR-1. In contrast, a smaller PR protein,
likely derived from XPR-2, was only present in the oocytes
and was referred to as XPR-2. Treatment of follicle cells with
progesterone caused disappearance of XPR-1 consistent with
proteosome-mediated XPR-1 degradation. Treatment of
oocytes with progesterone caused XPR-2 retardation on
SDS-PAGE analyses, likely reflecting XPR-2 phosphoryla-
tion. These biochemical changes were correlated with the
transcription-dependent (genomic) action of progesterone in
the follicle cells and transcription-independent (non-
genomic) action of progesterone in oocyte maturation.Materials and methods
Reagents
Cholera toxin A subunit was purchased from Sigma,
dissolved in water to 0.1 Ag/Al, and stored as single-use
aliquots at 70-C. SYTOX\ green nuclear stain was
purchased from Molecular Probes. Anti-cylcinB2 antibody
was kindly provided by J. L. Maller (University of Colorado,
Boulder). Anti-xMAP kinase and anti-Xenopus nucleolinXPR-1 (Tian et al., 2000) (GenBank accession no. AF279335) and XPR-2
esignated the putative initiation codon for XPR-2. Regions comprising the
ain (single underlined) are indicated. Identical amino acids are highlighted.
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inson Cancer Research Center, Seattle) and P.J. DiMario
(Louisiana State University, Baton Rouge), respectively.
Rabbit anti-XPR-2 antisera were raised against a GST fusion
protein containing XPR-2 amino acids 49–263 (Fig. 1), as
previously described (Bayaa et al., 2000). Monoclonal anti-h
tubulin antibody was purchased from ICN Biomedicals.
Other chemicals were purchased from Sigma.
Isolation of oocytes and follicle cells
Adult female X. laevis frogs were purchased from
NASCO. Frogs were primed with pregnant mare serum
gonadotropin (Sigma; 50 IU/frog) 3 to 10 days before use.
Stage VI oocytes were manually isolated from ovarian
tissues, taken from a sacrificed frog. Such manually
‘‘defolliculated’’ oocytes are associated with the inner most
layer of follicle cells (Sheng et al., 2005; Smith et al., 1968).
To remove these follicle cells, we incubated the oocytes in a
dish coated with fine sandpaper (Sheng et al., 2005). The
follicle cells removed from these oocytes were used for
experiments shown in Fig. 5. For most experiments shown
here, sandpaper-treated oocytes were used. These oocytes
were free from follicle cell contamination as judged by the
absence of follicle cell nuclei on the oocyte surface when the
oocytes were fixed and stained with SYTOX\ green (Sheng
et al., 2005). To obtain oocytes of various stages (Fig. 4A),
ovarian pieces were incubated with calcium-free OR2 (OR2:
83 mM NaCl, 2.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 1
mMNa2HPO4, 5 mMHEPES, pH 7.8) containing 1.5 mg/ml
of collagenase A (Roche Scientific), 1 mg/ml soybean
trypsin inhibitor. Oocytes of the different stages released
from the follicles were sorted according to Smith et al.
(1991). Collagenase-treated oocytes were also free from
follicle cell contamination, as judged by SYTOX\ green
staining (not shown).
Expression plasmids and in vitro transcription
Myc-XPR-249–631, which has been described previously
as Myc-xPR (Bayaa et al., 2000), contained 5 copies of the
13-amino acid Myc tag (Turner and Weintraub, 1994)
followed by the XPR-2 insert (49–631aa) (Fig. 1). Two
additional Myc-tagged XPR-2 were constructed: Myc-XPR-
2-N and Myc-XPR-2-C containing XPR-2 amino acids 49–
263 and 317–631, respectively. Untagged XPR-249–631
(amino acids 49–631) was inserted into pSP6TM vector
(Farah et al., 1998). The untagged full-length XPR-1 (1–
732aa) expression plasmid was a gift from J. V. Ruderman
(Harvard Medical School, Boston) (Tian et al., 2000).
Plasmids were linearized before subjected to in vitro tran-
scription reaction using mMESSAGE mMACHINE\ SP6
Kit (Ambion, Austin, TX). The 5V capped mRNA was
dissolved in water to 1 mg/ml and 10 nl was injected per
oocyte. Oocytes were incubated in OR2 at 18-C for
overnight, unless otherwise indicated.In vitro ovulation/maturation assays using follicle fragments
Ovary fragments containing 40–60 stage VI oocytes were
separated using forceps. These fragments were washed in
calcium-free OR2 and then transferred to 12-well culture
plates with 2 ml OR2 containing gentamycin (100 Ag/ml),
plus the appropriate reagents for ‘‘ovulation’’ induction.
After overnight incubation, the plate was placed on a rocking
platform to assist the separation of ‘‘ovulated’’ oocytes from
the ovarian tissues. ‘‘Ovulated’’ oocytes and stage VI oocytes
still trapped in the ovarian tissues were also examined for
germinal vesicle breakdown or GVBD (absence of germinal
vesicle upon fixation with 10% trichloric acid solution and
bisection). For the cholera toxin experiments, the toxin was
directly injected into stage VI oocytes still attached to the
ovarian tissues. However, because not all stage VI oocytes in
the ovarian fragments were accessible, a small percentage of
the stage VI oocytes were inevitably missed in these
injection experiments.
Enucleation experiments
Enucleation was performed in Joe Gall’s medium plus
Mg2+ (83 mMKCl, 17 mMNaCl, 1 mMMgCl2, 10 mM Tris
pH 7.2) (Gall et al., 1991) at room temperature. Isolated
nuclei were washed briefly and then transferred to 1 ml of
ice-cold enucleation buffer (100 mM NaAc pH 5.2, 5 mM
EDTA). Nuclei were collected by centrifuging at 2000 rpm
for 30 s in 4-C. Supernatant was aspirated and sample buffer
was added directly to lyse nuclei for immunoblot analyses.
Follicle cell isolation and incubation
A group of 160 oocytes was placed in a dish coated with
very fine sandpaper (0.05 Am Sandpaper, Fiberlap, Tucson,
Arizona, USA) containing 8 ml OR2 without CaCl2. After 2-
h stripping, oocytes were removed and the medium contain-
ing the follicle cells was transferred to a 15-ml Falcon tube
and vortex briefly. The cell suspension was then aliquoted to
1.5 ml Eppendorf tube, each containing follicle cells derived
from 20 manually ‘‘defolliculated’’ oocytes. After overnight
incubation at 18-C with the various reagents, follicle cells
were collected by centrifuging at 2500 rpm for 5 min at 4-C.
Supernatant was aspirated and SDS sample buffer was added
directly to the cell pellet to lyse the cells for immunoblot
analysis.
Oocyte protein extraction and immunoblot analysis
For protein isolation, oocytes were lysed by forcing
them through pipette tips in PBS lysis buffer (10 mM
sodium phosphate, pH 7.5, 150 mM NaCl, 1% Triton X-
100, 10 Ag/ml leupeptin, 1 mM phenylmethylsulfonate; 10 Al
lysis buffer per oocyte). The homogenate was centrifuged in
an Eppendorf centrifuge for 5 min at 4-C. The clarified
lysates were collected, mixed with SDS sample buffer, and
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alkaline phosphatase treatment, oocytes were similarly
lysed in PBS lysis buffer with the exception that 0.5 Al
lysis buffer was used per oocyte. Following centrifugation,
3 Al of extracts was diluted to 30 Al in CIAP (calf intestine
alkaline phosphatase, purchased from Gibco) buffer.
Dephosphorylation was initiated by the addition of 9 U
of CIAP and samples were incubated at 37-C for the
indicated period of time before the addition of SDS-sample
buffer.
SYTOX \ green staining
Oocytes were fixed with methanol at room temperature for
a minimum of 1 h. Fixed oocytes could be stored at20-C or
were immediately rehydrated by incubating 5 min in 75%,
50%, and 25% methanol/TBS (10 mM Tris buffer, 150 mM
NaCl). Rehydrated oocytes were transferred to 0.5  TBS
buffer containing SYTOX\ green (1:2000 dilution). A polar
body and the nearby metaphase II chromosome array became
visible following relatively short incubation (30 min) in
SYTOX\ green solution. We used a fluorescence dissection
scope (Leica MZ FLIII) for this purpose.
Reproducibility
All experiments presented here have been performed at
least three times (often more), each from a different donor
frog. Data shown here are representative of the multiple
experiments.Fig. 2. The mobility change of PR proteins after progesterone stimulation.
(A) Control oocytes (uninjected, lanes 3 and 4) and oocytes injected with the
indicated mRNA were incubated overnight in the absence () or presence
(+) of progesterone. In all cases, oocytes remained at the GV stage in the
absence of progesterone and completed oocyte maturation in the presence of
progesterone (indicated by GVBD). Extracts were prepared and analyzed by
SDS-PAGE followed by immunoblotting with antibodies against XPR-2.
The bottom panel represents longer (lanes 3 and 4) and shorter (lanes 5 and
6) exposures, respectively, of the corresponding region of the upper panel.
The start (*) indicates previously identified PR protein (Bayaa et al., 2000).
(B) Experimental details were the same as in panel A. (C) Experimental
details were the same as in panel A except that antibodies against Myc were
used instead of antibodies against XPR-2 for the immunoblotting. (D)
Extracts were prepared from GV (lane 1) and GVBD (lanes 2 to 6) oocytes.
Aliquots of the GVBD extracts were incubated with CIAP buffer (lane 3) or
CIAP for the indicated period of time. Samples were immunoblotted with
antibodies against XPR-2. This experiment was repeated another time and
almost-identical results were obtained.Results
Two forms of PR proteins differentially expressed in the
oocytes and in the follicle cells
We have previously identified a prominent cytoplasmic
protein as the oocyte-resident PR protein (Fig. 2A, indicated
by *) (Bayaa et al., 2000). However, we consistently noticed
other, more minor bands in these immunoblots. The
presence of multiple proteins recognized by antibodies
against XPR-2 remained unsettling until we realized that
one of these more minor proteins (arrow) completely shifted
to a slower-migrating band in oocytes that had undergone
progesterone-induced GVBD (Fig. 2A, lane 4). These
observations suggested that this more minor protein likely
represented endogenous PR protein. To further investigate
this possibility, we injected untagged XPR-1 (Tian et al.,
2000) (Fig. 2A, lanes 1 and 2), untagged XPR-249–631 (Fig.
2B, lanes 3 and 4), or Myc-tagged XPR-249–631 (Bayaa et
al., 2000) (Fig. 2A, lanes 5 and 6) and confirmed that all
three underwent progesterone-induced shift similar to that
exhibited by the endogenous protein. The endogenous
oocyte PR protein had an apparent molecular mass of about
70 kDa and was smaller than untagged XPR-1 but greaterthan untagged XPR-249–631. We termed this oocyte protein
XPR-2, in reference to XPR-1 (see later). Analyses of two
truncated forms of XPR-2 indicated that the N-terminus of
XPR-2 contained sequences responsible for this mobility
shift (Fig. 2C, lanes 3 and 4). Treatment of oocyte extracts
with alkaline phosphatase (Fig. 2D) or acid phosphatase
(not shown) converted the slower-migrating band back to
the faster-migrating band (compare lane 3 for buffer control
Fig. 3. Time course of progesterone-induced XPR-2 phosphorylation. (A)
More than 100 oocytes were stimulated with 1 AM progesterone (pg), and, at
the indicated time, a group of 5 oocytes was randomly withdrawn and lysed
for Western blotting using anti-XPR-2, anti-MAPK, or anti-cyclinB2
antibodies. At 2.5 h, 62 out of 88 oocytes underwent GVBD. This batch
of oocytes was very synchronous in GVBD responses and, as a result, the
degradation of cyclinB2 following GVBD (lane 8) and its subsequent re-
synthesis (lanes 9 and 10) were evident without the need to select oocytes
based on the appearance of GVBD spot. (B) After overnight stimulation with
1 AM progesterone, 100 mature eggs were pooled and calcium ionophore
A23187 (2 Ag/ml) was added to trigger parthenogenetic activation. A group
of 10 oocytes was removed at each time point, and lysed for Western blotting
using anti-XPR-2, anti-MAPK, and anti-cyclinB2 antibodies. As a control,
we also analyzed GVoocytes (lane 1) and GVoocytes treated with A23187
(lane 2). (C) Oocytes were pre-incubated for 1 h with (+) or without 100 AM
U0126, and then stimulated with 1 AM progesterone. The time when more
than 90% of control oocytes underwent GVBD was considered as time ‘‘0’’,
and a group of 10 oocytes was removed at each time point after that, and
lysed for Western blotting using anti-XPR-2, anti-MAPK, and anti-cyclinB2
antibodies. Lanes 1 and 2 are GVoocytes treated (+) or not () with U0126,
but not with progesterone.
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protein phosphorylation.
Time course experiments indicated that progesterone-
induced XPR-2 phosphorylation was not observed immedi-
ately following the addition of progesterone. Rather, it
occurred at about the same time when oocytes underwent
germinal vesicle breakdown (GVBD) and when p42 MAP
kinase and MPF (maturation promoting factor) were
activated (Fig. 3A). XPR-2 remained as the phosphorylated
form throughout meiosis I/meiosis II transition, during
which MAP kinase remained phosphorylated (activated)
while MPF underwent a transient inactivation as indicated by
the degradation and re-synthesis of cyclin B2 (Fig. 3A, lanes
8 to 12). When mature eggs were treated with the calcium
ionophore A23187, used for parthenogenetic activation
(Belanger and Schuetz, 1975; Masui et al., 1977), XPR-2
became dephosphorylated (Fig. 3B). XPR-2 dephosphor-
ylation was again temporally similar to MAP kinase
dephosphorylation.
To determine whether MAP kinase activation has a role in
XPR-2 phosphorylation, we utilized a specific MEK
inhibitor U0126. Inhibition of MEK abolished MAP kinase
activation but only delays MPF activation and GVBD (Gross
et al., 2000). In the presence of U0126, MPF activation
(indicated by the upward shift of cyclin B2) was delayed
about 1 h (Fig. 3C, lane 6) compared to control oocytes (lane
3). At this point, MAP kinase was inactive (indicated by a
single faster migrating band, lane 6) and no phosphorylation
of XPR-2 occurred in U0126-treated cells. XPR-2 was only
partially phosphorylated even when U0126-treated oocytes
had undergone GVBD, with MAP kinase still inactive (lanes
8 and 10). These data suggested that XPR-2 phosphorylation
was influenced by the MAP kinase pathway but was
independent of MPF.
XPR-2 was present in oocytes of all developmental stages
(Fig. 4A). Manual dissection of oocyte nucleus (germinal
vesicle) followed by immunoblotting indicated that the
majority of XPR-2 was present in the oocyte nucleus
(¨74% of total). Significant proportion (¨21% of total;
the remaining ¨5% was presumably lost during the manual
manipulations) was recovered in the enucleated oocytes (Fig.
4B). Cross-contaminations were minimal as indicated by the
nuclear (nucleolin) (DiMario and Gall, 1990) and cytopals-
mic (h-tubulin) protein markers. Progesterone treatment of
oocytes (from 5 min up to 2–3 h, beyond which time point
GVBD started to occur) did not change the ratio of nuclear/
cytoplasmic XPR-2 (not shown).
The apparent absence of XPR-1 in the oocytes, which is
consistent with the earlier report by Tian et al. (2000) that
frog oocytes contain very low, if any, XPR-1 mRNA,
prompted us to ask whether XPR-1 might be differentially
expressed in somatic cells in the follicles. We recovered
follicle cells following stripping manually ‘‘deffoliculated’’
oocytes (Sheng et al., 2005). Immunoblotting analyses of
extracts from these follicle cells indeed detected a protein
indistinguishable from the cloned XPR-1 (Fig. 5A). In
Fig. 4. XPR-2 is present throughout oogenesis and is predominantly
nuclear. (A) Oocytes of different stages were selected following treatment
of ovarian tissues with collagenase A (Roche) (Smith et al., 1991). Extracts
made from oocytes of equal weight (equivalent to half of one stage VI
oocyte) were analyzed by immunoblotting using anti-XPR-2 and anti-h-
tubulin antibodies. (B) A group of 5 oocytes were enucleated in Gall’s
medium. The nuclei and enucleated oocytes were lysed and subjected to
Western analysis using anti-XPR-2, anti-nucleolin, and anti-h-tubulin
antibodies. Each lane represents materials derived from 1 oocyte. Shown
is representative of five independent experiments (left panel). The film was
scanned and XPR-2 band was quantified using Molecular Dynamics
software (Pharmacia Biotech). The results of these analyses are shown in
the right panel (averages of five experiments with standard errors).
Fig. 5. XPR-1 in follicle cells. (A) An aliquot of follicle cells stripped from
20 oocytes was lysed for Western blotting using anti-XPR-2 antibodies.
Also loaded is a sample from control oocytes and oocytes injected with
XPR-1 mRNA (each representing one oocyte). (B) Follicle cells were
isolated, aliquoted (each derived from 20 manually ‘‘defolliculated’’
oocytes), and stimulated with 1 AM progesterone (pg). One aliquot was
taken at each time point and the extracts were analyzed by Western blotting
using anti-XPR-2 and anti-MAPK antibody. (C) Follicle cells were isolated,
aliquoted (each derived from 20 manually ‘‘defolliculated’’), and pre-
incubated for 1 h with vehicle (DMSO), 100 AM U0126, or 100 AM
lactacystin, and then treated with 1 AM progesterone or 1 AM testosterone.
After overnight incubation, follicle cells were lysed for Western blotting
with anti-XPR-2 and anti-h-tubulin antibodies, respectively.
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detectable in these follicle cells. Interestingly, treating these
follicle cells with progesterone caused time-dependent
disappearance of XPR-1, with a half-life of less than 8 h.
In contrast, testosterone did not cause this disappearance. As
a control, the levels of p42 MAP kinase (or h-tubulin, see
Fig. 5C) did not change significantly regardless whether
these cells were treated with progesterone or not (Fig. 5B).
U0126 inhibited progesterone-induced XPR-1 disappear-
ance (Fig. 5C). Progesterone-induced degradation of XPR-
1 in the follicle cells was completely inhibited by a
specific proteosome inhibitor lactacystin (Fig. 5C), sug-
gesting the involvement of ubiquitin–proteosome pathway
(Lange et al., 2000).
Transcription-dependent and transcription-independent
functions of progesterone in the ovaries
Previous studies have established that progesterone-
induced MPF activation does not require the presence of
the germinal vesicle (Masui and Markert, 1971; Schorderet-
Slatkine and Drury, 1973), effectively eliminating the need
for gene transcription for MPF activation. Furthermore,
treating oocytes with actinomycin D does not preventprogesterone-induced GVBD (Schorderet-Slatkine, 1972).
However, it is conceivable that other maturation events after
GVBD may require transcription. To test the possibility that
transcription activities may be required for meiosis I to
meiosis II transition, we treated oocytes with actinomycin D.
Fig. 6 shows that oocytes treated with actinomycin D undergo
similar biphasic pattern of MPF activation, indicated by
cyclin B degradation and re-syntheses. Actinomycin D
inhibits transcription by binding to chromosomal DNA and,
in doing so, interferes with chromosome segregation during
maturation (Jagiello, 1969; Ziegler and Masui, 1976). This
caveat prevented its use in determining whether inhibition of
transcription would affect chromosomal dynamics during
oocyte maturation. To circumvent this caveat, we employed
a-amanitin, a specific inhibitor of RNA polymerase II, to
inhibit transcription (Leonard and Patient, 1991). Injecting
oocytes with a-amanitin completely blocked expression of a
Fig. 6. Effect of transcription inhibitors on MI–MII transition. (A) 50
oocytes were pre-incubated with 5 Ag/ml actinomycin D for 1 h. Control
oocytes or oocytes pretreated with actinomycin D were then incubated with
1 AM progesterone. A group of 5 oocytes was removed at each time point,
and lysed for Western blotting using anti-MAPK and anti-cyclinB2
antibodies.
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panels a and b), indicating the effectiveness of inhibition of
transcription. However, oocytes injected with a-amanitin,
like control oocytes, completed meiosis I and arrested at
metaphase II (Fig. 7, panels c and d). These results extended
earlier studies and established that inhibition of transcription
did not interfere with the completion of meiosis I and
metaphase II arrest.
Earlier studies have demonstrated that pituitary hormone
(gonadotropin)-induced oocyte maturation and ovulation is
inhibited by actinomycin D and by cyanoketone, implyingFig. 7. Inhibition of transcription did not interfere with oocyte maturation. Oocyte
incubated for 1 h. Control oocytes and the a-amanitin-injected oocytes were each s
expression plasmid (Ma et al., 2003) (0.2 Ag/Al, 5 nl per oocyte) and groups c and
were visualized with a fluorescence microscope directly. It was evident that injecti
d were fixed and stained with SYTOX\ green followed by fluorescence microsco
polar body.the involvement of RNA synthesis (transcription) and
steroidogenesis, respectively (Smith and Ecker, 1970). In
contrast, progesterone-induced ovulation is not affected by
cyanoketone, indicating that the production of progesterone
alone is sufficient to effect ovulation (Wright, 1971). We
wished to compare gonadotropins and progesterone in an in
vitro maturation/ovulation system. In particular, we wished
to dissociate the transcription-dependent and transcription-
independent action of progesterone in the same experimental
system. As shown previously (Smith and Ecker, 1970),
treating isolated ovary pieces with human chorionic gona-
dotropin (hCG) or with progesterone caused release of the
mature oocytes (Fig. 8A). Using this in vitro system, we
demonstrated that actinomycin D blocked progesterone-
induced ‘‘ovulation’’, as reported previously (Yatvin and
Pitot, 1969), but not oocyte maturation such that mature
oocytes were trapped in the follicles (Fig. 8B). In contrast,
actinomycin D blocked both ovulation and maturation
induced by hCG (Fig. 8C). To determine whether oocyte
maturation was a pre-requisite for ovulation, we injected
follicle-enclosed oocytes with cholera toxin A subunit,
which should only act within the injected cells. Cholera
toxin A is a potent inhibitor of oocyte maturation (Maller et
al., 1979), through its ability to activate Gsa by ADP-
ribosylation (Bokoch et al., 1983). Surprisingly, cholera
toxin A inhibited progesterone-induced ‘‘ovulation’’ to the
same degree as it inhibited progesterone-induced oocyte
maturation (Fig. 8D). In contrast, injection of cholera toxin As were first injected with a-amanitin (10 mg/ml, 20 nl per oocyte) and then
plit into two groups. Groups a and b received a nuclear injection with a GFP
d were treated with progesterone. After overnight incubation, groups a and b
on of a-amanitin completely inhibited GFP expression (b). Oocytes in c and
py. Shown are representatives of more than 50 oocytes in each group. PB =
Fig. 8. Oocyte maturation and ovulation in ovarian fragments. (A) Representative images of ovarian fragments incubated overnight in OR2 (control), OR2
containing hCG (50 IU per ml), or progesterone (10 AM). (B) The effect of actinomycin D on progesterone-induced ovulation/maturation. Shown here are
results (averages with standard errors) from three independent experiments. (C) The effect of actinomycin D on hCG-induced ovulation/maturation. Shown
here are results (averages with standard errors) from three independent experiments. (D) The effect of cholera toxin A injection on oocyte maturation and
ovulation. Shown here are results (averages with standard errors) from five independent experiments. Control ovarian fragments did not exhibit any oocyte
maturation or ovulation.
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of oocytes from the ovarian tissues; therefore, immature
oocytes were ‘‘ovulated’’ (Fig. 8D). As the ovary pieces
contained some fully grown oocytes that were not accessible
to injection, the approximately 25% of the oocytes that were
successfully matured and released from the follicles in‘‘toxin-treated’’ groups actually represented those interior
oocytes that were missed during the toxin injection. The
differential effects of cholera toxin injection on progesterone-
induced vs. hCG-induced ‘‘ovulation’’ suggested that hCG-
induced follicle rupture involves redundant steroid pathways
(discussed later).
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Two forms of PR proteins and their respective functions
The presence of two immuno-reactive PR proteins (XPR-
1 and XPR-2) is reminiscent of two PR proteins (PR-B and
PR-A) in other organisms. However, PR-A and PR-B are
derived from the same gene through alternative splicing.
Sequence analyses revealed that XPR-1 contained an
internal ATG codon (Met89) homologous to the translational
initiation codon for the hPR-A isoform (Tian et al., 2000).
The putative protein derived from this alternative start
codon of XPR-1 would have a molecular weight of 72.5
kDa, roughly the size of oocyte XPR-2. However, XPR-1
mRNA levels are extremely low (Tian et al., 2000) and
XPR-1 protein was undetectable (this study) in frog oocytes.
In contrast, significant amounts of XPR-2 mRNA are
present in frog oocytes (Bayaa et al., 2000). Furthermore,
as indicated in Fig. 1, the available open reading frame of
XPR-2 would encode a protein of MW = 71,204.15,
consistent with the apparent molecular weight of the oocyte
XPR-2. It should be pointed out that the available XPR-2
cDNA clones may not represent the full-length cDNA, as no
in-frame translation termination codons are found 5V to ATG
codon (Bayaa et al., 2000) (AY007198; and Tian and
Ruderman, AF319596). Based on these analyses, we
concluded that the 70-kDa XPR-2 found in frog oocytes
was derived from the open reading frame of XPR-2 shown
in Fig. 1 (amino acids 1–631).
The different expression patterns of the two PR proteins
and their distinct biochemical behaviors (progesterone-
induced XPR-1 degradation in follicle cells vs. progester-
one-induced XPR-2 phosphorylation in the oocytes) would
argue that they mediate different functions of progesterone in
the ovaries. We demonstrated for the first time that the
follicle-resident XPR-1 underwent progesterone-induced
degradation. Similar to PR degradation in mammalian
somatic cells (Shen et al., 2001), degradation of XPR-1 in
frog follicle cells was dependent on MAP kinase signaling
and was mediated by the ubiquitin pathway. These similar-
ities clearly suggest that XPR-1 was responsible for the
genomic (transcription dependent) action of progesterone in
ovulatory responses.
That XPR-2 in frog oocytes underwent progesterone-
induced phosphorylation but not degradation was intriguing.
We speculate that the lack of XPR-2 degradation in the
oocytes was attributed to the specific cellular environment
of the oocytes (e.g., the lack of a specific ubiquitin ligase
responsible for polyubiquitination of PR proteins) and not
intrinsic to XPR-2, as XPR-1 derived from mRNA
injection also underwent phosphorylation and not degra-
dation in the oocytes (Fig. 2A, lanes 3 and 4). The role
of XPR-2 phosphorylation in the oocytes is not clear. The
timing of the XPR-2 phosphorylation coincided with the
‘‘all-and-none’’ switch in MAP kinase activation (Ferrell
and Machleder, 1998) and GVBD, several hours follow-ing the initial addition of progesterone, suggesting that
XPR-2 phosphorylation did not represent an initial
signaling event. Furthermore, XPR-2 was completely
shifted to the phosphorylated form following GVBD,
suggesting that both the cytoplasmic and the nuclear
portions of XPR-2 became phosphorylated at the same
time, when the nuclear boundary disappeared. These
results suggest that XPR-2 phosphorylation may represent
a feedback mechanism, in which phosphorylation of
XPR-2 by a protein kinase in the MAP kinase signaling
pathway may alter the functional state of XPR-2.
Alternatively, XPR-2 phosphorylation may not have any
physiological role in progesterone signaling, as similar
XPR-2 phosphorylation also occurred in oocytes treated
with testosterone (at the time of GVBD) (not shown),
even though testosterone signals through the androgen
receptor (Lutz et al., 2001). Nonetheless, the indistin-
guishable mobility shift of the endogenous XPR-2 and
other PR proteins derived from mRNA injection provided
strong confirmation that this protein indeed represented
endogenous PR.
Identity of the non-genomic progesterone receptor in frog
oocytes
The ability of progesterone to induce MPF activation in
enucleated oocytes firmly establishes the non-genomic
nature of progesterone action in frog oocytes (Masui and
Markert, 1971; Schorderet-Slatkine and Drury, 1973).
Furthermore, progesterone is able to induce MPF activation
as well as GVBD in the presence of inhibitors of tran-
scription, indicating that neither MPF activation nor GVBD
is dependent on progesterone-induced transcription activa-
tion. However, it remains conceivable that progesterone-
induced transcription is required for the completion of
meiosis (i.e., proceeding to and arresting at metaphase II).
Indeed, whether or not the germinal vesicle plays a role in
the biphasic pattern of MPF activation (Gerhart et al., 1984)
remains controversial (Fisher et al., 1998; Iwashita et al.,
1998). We have carried out similar enucleation experiments
and our data were in agreement with those of Fisher et al.
(1998) in that enucleated oocytes exhibited biphasic pattern
of MPF activation (not shown). In support of this notion are
our present results indicating that inhibition of transcription
did not affect the biphasic MPF activities (Fig. 6), nor did it
affect the normal chromosome dynamics during oocyte
maturation (Fig. 7). Therefore, progesterone-induced oocyte
maturation, as judged by MPF activities and by the proper
chromosome progression, is truly non-genomic.
Our current study supports the notion that XPR-2 is
responsible for this non-genomic action of progesterone in
inducing oocyte maturation. An alternative, or perhaps
additional, mechanism has been suggested (Maller, 2003)
with the recent cloning of a putative membrane receptor
(mPR) for 17a, 20h-dihydroxy-4-pregnen-3-one (17a, 20h-
P) in sea trout (Zhu et al., 2003a) and its homolog in the frog
X.S. Liu et al. / Developmental Biology 283 (2005) 180–190 189(Zhu et al., 2003b). mPR is a Gi-coupled receptor (Zhu et
al., 2003a) and therefore it represents a good candidate as
the progestin receptor in fish oocytes, as progestin-induced
fish oocyte maturation is Gi-dependent. However, there is
overwhelming evidence indicating that, in contrast to fish
oocyte maturation, progesterone-induced amphibian oocyte
maturation does not involve Gi. First, progesterone-induced
oocyte maturation is not sensitive to pertussis toxin (a
classical Gi inhibitor) (Sadler et al., 1984; Sheng et al.,
2001). Second, activating endogenous Gi by over-expression
of multiple Gi-coupled receptors does not induce frog oocyte
maturation (Kalinowski et al., 2003; Noh and Han, 1998;
Romo et al., 2002). Third, direct injection of activated Gi
does not induce oocyte maturation (Kroll et al., 1991).
Therefore, it remains possible that different mechanisms
have evolved to mediate steroid action in fish and amphibian
species.
Steroid redundancies
The function of progesterone as a mediator of gonado-
tropic hormones in the induction of ovulation in mammals is
well established. Earlier work has indicated that the specific
and potent antagonist of PR, RU486, blocked LH-induced
ovulation in many mammalian species (Ledger et al., 1992;
Loutradis et al., 1991; Sanchez-Criado et al., 1990). The
role of progesterone in ovulation was confirmed many years
ago by Lydon et al. (1995) who showed that mice lacking
the PR gene (generated through homologous recombination)
failed to ovulate when injected with LH. However, the
ovaries of these mice appear to contain fully mature oocytes,
indicating that PR is not required for mouse oocytes to
undergo meiotic maturation (Lydon et al., 1995; Robker et
al., 2000).
Although progesterone can clearly trigger oocyte matu-
ration in vitro in frogs, whether progesterone is essential for
oocyte maturation to occur in vivo is not clear. Indeed, there
are redundant steroid pathways (progesterone and andro-
gens) to trigger frog oocyte maturation in vitro (Fortune et
al., 1975; Lutz et al., 2001). Similarly, both progesterone
and androgens (testosterone and androstenedione) can
induce ‘‘ovulation’’ in vitro (Morrill and Bloch, 1977) (our
unpublished data). Furthermore, while progesterone-
induced ‘‘ovulation’’ was inhibited when oocyte maturation
was blocked (by injection of cholera toxin directly into the
follicle-enclosed oocytes), hCG-induced ‘‘ovulation’’ was
not affected by this maturation blockade. These results
clearly indicated that hCG (or LH) can induce ovulation
through multiple pathways. Why the redundant pathways?
We propose that the presence of multiple LH-induced
pathways to stimulate oocyte maturation and ovulation is
to ensure that the two processes are highly coordinated. The
need for this coordination is obvious as mature eggs trapped
in the ovaries (in a condition called preovulatory over-
ripeness of the oocytes) will degenerate and cause repro-
ductive failure (Smits et al., 1995). On the other hand,immature oocytes, if released from the ovaries, are not
capable of fertilization.Acknowledgments
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